Smoflipid
Payments companies reported to CMS as associated with Smoflipid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Smoflipid, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Smoflipid
These are the largest totals companies reported as associated with Smoflipid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Fitzgerald | Aurora, CO | Neonatal-Perinatal Medicine | $110,322.06 |
| David Evans | Columbus, OH | Trauma Surgery | $71,136.53 |
| Robert Martindale | Portland, OR | Surgery | $19,386.88 |
| Sivan Kinberg | New York, NY | Pediatric Gastroenterology | $16,179.52 |
| Merin Kinikini | Salt Lake City, UT | Nurse Practitioner | $14,972.96 |
| Naveen Mittal | Dallas, TX | Pediatric Gastroenterology | $14,090.33 |
| Louis Guzzi | Orlando, FL | Critical Care Medicine (Anesthesiology) | $11,759.55 |
| Talat Ikizler | Nashville, TN | Nephrology (Internal Medicine) | $5,410.00 |
| Paul Wischmeyer | Aurora, CO | Critical Care Medicine (Anesthesiology) | $3,177.71 |
| Jack Pasquale | Roslyn, NY | Internal Medicine | $495.98 |
Prescribed Smoflipid?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.